Showing results (1-10 of 41) with videos related to
Sort By:
Pageof 5
Emerging Infectious Diseases|September 6, 2011
High rates of malaria among US military members born in malaria-endemic countries, 2002-2010Ellen R Wertheimer, John F Brundage, Mark M FukudaMicrobiology and Immunology|December 4, 2009
Characteristics of stork feces-derived H5N1 viruses that are preferentially transmitted to primary human airway epithelial cellsAmpa Suksatu, Wichayapong Sangsawad, Arunee Thitithanyanont, et al.International Ophthalmology|October 1, 2018
Comparative ophthalmic assessment of patients receiving tafenoquine or chloroquine/primaquine in a randomized clinical trial for Plasmodium vivax malaria radical cureSukhuma Warrasak, Ataya Euswas, Mark M Fukuda, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 5, 2007
IL-8 and IDO expression by human gingival fibroblasts via TLRsRangsini Mahanonda, Noppadol Sa-Ard-Iam, Pattanin Montreekachon, et al.Malaria Journal|June 28, 2008
Polymorphism patterns in Duffy-binding protein among Thai Plasmodium vivax isolatesPanita Gosi, Srisin Khusmith, Thareerat Khalambaheti, et al.Malaria Journal|September 8, 2007
World Antimalarial Resistance Network (WARN) II: in vitro antimalarial drug susceptibilityDavid J Bacon, Ronan Jambou, Thierry Fandeur, et al.Malaria Journal|August 15, 2012
Evaluation of dihydrofolate reductase and dihydropteroate synthetase genotypes that confer resistance to sulphadoxine-pyrimethamine in Plasmodium falciparum in HaitiTamar E Carter, Megan Warner, Connie J Mulligan, et al.BMC Public Health|March 11, 2011
The Global Emerging Infection Surveillance and Response System (GEIS), a U.S. government tool for improved global biosurveillance: a review of 2009Kevin L Russell, Jennifer Rubenstein, Ronald L Burke, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 30, 2010
Artemisinin resistance in Cambodia: a clinical trial designed to address an emerging problem in Southeast AsiaHarald Noedl, Youry Se, Sabaithip Sriwichai, et al.Plos One|November 10, 2017
A randomized, double-blind, active-control trial to evaluate the efficacy and safety of a three day course of tafenoquine monotherapy for the treatment of Plasmodium vivax malariaMark M Fukuda, Srivicha Krudsood, Khadeeja Mohamed, et al.Pageof 5